Cart
sales@molnova.com
Home - Products - GPCR/G Protein - Dopamine Receptor - Gemcitabine monophosphate sodium salt hydrate

Gemcitabine monophosphate sodium salt hydrate

CAS No. 1638288-31-9

Gemcitabine monophosphate sodium salt hydrate( —— )

Catalog No. M18102 CAS No. 1638288-31-9

Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 178 In Stock
25MG 340 In Stock
50MG 567 In Stock
100MG 956 In Stock
200MG 1474 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Gemcitabine monophosphate sodium salt hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
  • Description
    Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Autophagy| DNA| Thymidylate synthase| UMP-CMP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1638288-31-9
  • Formula Weight
    405.16
  • Molecular Formula
    C9H12F2N3Na2O8P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=c1nc(N)ccn1[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@@H](O)C1(F)F.[Na+].O.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Miao L, et al.Adv Funct Mater. 2014 Nov 12;24(42):6601-6611. PubMed PMID: 25395922; PubMed Central PMCID: PMC4225819.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Bromopride

    Bromopride is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic.

  • ONC206

    ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??

  • Dexpramipexole

    A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.

Sign In Join Free